UBS raises Crocs stock price target to $145 on strong results
UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.
How this was made
The 30-second read
Why it matters
Analyst price target hikes often lead to short-term buying pressure, especially when accompanied by earnings beats.
Market read
The new target may attract momentum traders and support a modest rally in CROX.
What to watch
Macro uncertainty and cost pressures could curb future earnings growth.
Background
Crocs reported Q3 earnings that beat expectations, prompting multiple broker updates.
Ticker impact
UBS raised its price target for Crocs to $145 from $120 following better-than-expected Q3 results and raised guidance.
likely modest upside as the higher target supports buying interest
The new target is 21% above the prior level and reflects fresh earnings beat, prompting traders to consider buying on perceived undervaluation.
Market effects
Positive signal for the broader footwear and casual apparel sector as Crocs' earnings beat may lift peers.
U.S. market focus; no specific regional effect.
Limited to investors tracking consumer discretionary stocks.
Counterpoint
The neutral rating suggests upside may be limited; price may already be priced in.
Key entities
- companyCrocs Inc.
Footwear manufacturer whose stock is the subject.
- analystUBS
Investment bank that raised the price target.
